Skip to main content
MeVis Medical Solutions AG logo

MeVis Medical Solutions AG — Investor Relations & Filings

Ticker · M3V ISIN · DE000A0LBFE4 LEI · 529900Z8B6L1WCLNHW14 BE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 490 across all filing types
Latest filing 2024-10-10 Report Publication Anno…
Country DE Germany
Listing BE M3V

About MeVis Medical Solutions AG

https://www.mevis.de/en/

MeVis Medical Solutions AG is a developer and provider of software for image-based medical diagnostics and therapy. The company creates innovative solutions for the analysis and processing of image data, focusing on the early detection and diagnosis of diseases, particularly in oncology. Its clinical applications target breast, lung, liver, and neurological conditions. The software supports various imaging modalities, including magnetic resonance tomography (MRT), computed tomography (CT), digital mammography, tomosynthesis, and digital sonography. MeVis markets its products to manufacturers of medical devices and medical IT platforms, offering support throughout the product lifecycle from development to integration and quality assurance. The company also provides technical visualizations for professional education, research, and publication.

Recent filings

Filing Released Lang Actions
Hinweis auf Jahresfinanzbericht vom 01.10.2023 bis zum 30.09.2024
Report Publication Announcement Classification · 99% confidence The document is very short (794 characters) and explicitly functions as a notice. The subject line is 'Hinweis auf Jahresfinanzbericht vom 01.10.2023 bis 30.09.2024' (Notice of Annual Financial Report for the period...). It states where the financial report is available ('Im Internet unter:') and the date it will be available ('Im Internet am: 30.01.2025'). This structure perfectly matches the definition of a Report Publication Announcement (RPA), which announces the release or availability of a primary report, rather than being the report itself (like a 10-K or IR).
2024-10-10 German
Declaration of Conformity 2024
Governance Information Classification · 100% confidence The document is a formal 'Declaration of Conformity' with the German Corporate Governance Code (GCGC), as required by Section 161 of the German Stock Corporation Act (AktG). This type of document details the company's internal governance structure, board composition, and deviations from recommended governance practices. It fits perfectly into the 'Governance Information' category, which covers internal rules, board structure, and governance practices.
2024-09-09 English
MeVis Medical Solutions AG: Adjusting forecast for the current fiscal year
Earnings Release Classification · 100% confidence The document is explicitly labeled as an 'Ad-hoc' announcement dated September 4, 2024, disclosing 'inside information acc. to Article 17 MAR'. The core content is the adjustment of the annual forecast for the fiscal year 2023/2024, specifically revising expected sales and EBIT figures. This type of material, which provides preliminary financial results and outlook adjustments outside of a scheduled earnings release, is best classified as an Earnings Release (ER) or, given the context of MAR disclosure, a general Regulatory Filing (RNS). However, since it directly concerns the adjustment of expected financial results (sales and EBIT), it aligns most closely with the intent of an Earnings Release (ER), which covers periodical financial results, even if it's a mid-year revision/update rather than the final report. Given the options, ER is the most specific fit for a financial performance update, although RNS is also plausible for MAR disclosures. Since it details specific financial figures (sales and EBIT adjustments), ER is preferred over the general RNS. FY 2024
2024-09-04 English
Jahresfinanzbericht 2022/2023
Annual Report Classification · 100% confidence The document is a comprehensive 'Jahresabschluss' (Annual Financial Statement) for MeVis Medical Solutions AG for the fiscal year 2022/2023. It contains a management report (Lagebericht), balance sheet (Bilanz), profit and loss statement (Gewinn- und Verlustrechnung), cash flow statement (Kapitalflussrechnung), notes (Anhang), and the auditor's report (Bestätigungsvermerk). This structure corresponds to a full annual report, which is classified as a 10-K in the provided schema. FY 2023
2024-08-21 German
MeVis publishes figures for the first half of fiscal year 2023/2024
Earnings Release Classification · 100% confidence The document explicitly states it announces the "results for the first half of fiscal year 2023/2024" and provides key financial figures (revenue, EBIT, EBT) for the six-month period ending March 31, 2024. This content aligns perfectly with the definition of an Interim / Quarterly Report (IR). Although it is presented as a news release via EQS, the core content is the comprehensive financial summary for a period shorter than a year, making 'IR' the most accurate classification over 'ER' (which is usually just highlights) or 'RPA' (which only announces the release of a report, whereas this document contains the actual figures). H1 2024
2024-05-27 English
Halbjahresfinanzbericht nach WpHG zum Geschäftsjahr vom 01.10.2023 bis zum 31.03.2024
Interim / Quarterly Report Classification · 100% confidence The document is a 'Halbjahresfinanzbericht' (Half-Year Financial Report) for MeVis Medical Solutions AG for the period 01.10.2023 to 31.03.2024. It contains detailed financial statements, management discussion and analysis (Zwischenlagebericht), and operational performance data. It is a comprehensive interim report, not an announcement or a summary, and therefore fits the definition of an Interim/Quarterly Report (IR). H1 2024
2024-05-27 German

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.